Results 51 to 60 of about 40,749 (237)
Medicina, 2019 Euglycemic diabetic ketoacidosis (euDKA) related to sodium-glucose cotransporter 2 inhibitor (SGLT2-I), despite being reported as consistent, though infrequent, adverse effect in all trials on SGLT2-I in type 2 diabetes mellitus (T2D), still remains ...
Felice Nappi +6 more
doaj +1 more source
Inherited metabolic epilepsies–established diseases, new approaches
Epilepsia Open, EarlyView.Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley +1 more source
Exploring the Molecular Pathways Underlying the Anti‐Diabetic Effects of Millets
Food Safety and Health, EarlyView.Millet consumption may modulate gluconeogenesis and glycolysis, enhance glucose transporter activity, increase leptin levels, inhibit the NF‐κB pathway, and mitigate oxidative and nitrosative stress. ABSTRACT Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemic conditions resulting from inadequate insulin production or ...
Akash Kumar +5 more
wiley +1 more source
Learning Health Systems, EarlyView.Abstract Introduction Since being introduced by the Institute of Medicine (IoM) in 2007, the learning health system (LHS) concept has gained traction as a promising solution for achieving systems‐level healthcare transformation. This review of the LHS literature consolidates current understanding of LHS definitions, models, frameworks, and underlying ...
Louise A. Ellis +9 more
wiley +1 more source
PROTEOMICS – Clinical Applications, EarlyView.ABSTRACT Purpose Diabetes mellitus (DM) is a major cause of end‐stage kidney disease (ESKD), with kidney transplantation being the preferred treatment. However, post‐transplant diabetes mellitus (PTDM) increases mortality and graft loss. While PTDM and Type 2 diabetes mellitus (T2DM) share risk factors, their mechanisms differ, particularly in diabetic
Eleni Skandalou +7 more
wiley +1 more source
Fluid Therapy For Pediatric Patients With Diabetic Ketoacidosis: Current Perspectives
Diabetes, Metabolic Syndrome and Obesity, 2019 Muralidharan Jayashree, Vijai Williams, Rajalakshmi Iyer Division of Pediatric Emergency and Intensive Care, Department of Pediatrics, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, IndiaCorrespondence:
Jayashree M, Williams V, Iyer R
doaj
Journal of Nursing Management, Volume 30, Issue 8, Page 3765-3776, November 2022., 2022 Abstract Aim The aim of this review is to examine the effectiveness of artificial intelligence in predicting multimorbid diabetes‐related complications. Background In diabetic patients, several complications are often present, which have a significant impact on the quality of life; therefore, it is crucial to predict the level of risk for diabetes and ...
Lucija Gosak +3 more
wiley +1 more source
Addiction, EarlyView.Abstract Background and Aims Long‐term treatment of opioid dependence with the opioid agonist therapy (OAT) methadone can lead to significant weight gain. This study investigated whether OAT patients with a body mass index (BMI) deemed overweight (≥25) are at increased risk of mortality.
Thikra Algahtani +5 more
wiley +1 more source